Chem Outsourcing Conference 2017
- Date: 18-20 September 2017
- Place: New Jersey
Bio International Conference 2017
- Date: 19-22 June 2017
- Place: San Diego
Bio Asia 2017
- Date: 6-9 February 2017
- Place: Hyderabad
Laxai – Ferrer (ABAC Therapeutics)
- To develop First in class (FIC) antibiotics against life threatening infections.
- Laxai has been a strategic partner to ABAC Therapeutics.
- Technical platform validation.
- Delivered Pre-clinical Candidate with clean IP acting against gram-negative bacteria with unique mode of action.
Aptose Biosciences Announces Exclusive collaborations with Laxai for New Multi-Targeting Epigenetic Therapeutic Agents (10 November 2015)
- Laxai to Design Next Generation Epigenetic Therapeutics.
- Laxai has contributed in reviewing the target selection and devised the unique strategy with clear differentiation.